Fig. 8: RNAPath predictions of luminal A and Basal-like PAM50 signature genes.

RNAPath model predictions on the PAM50 signature, used to stratify breast cancer at molecular level, correlates with the ground truth, with luminal A samples (A) having low expression (blue) of CCNE1 (3.52) and high expression (red) of PGR (12.51) and basal-like samples B having high expression of CCNE1 (10.86) and low expression of PGR (2.65), as represented in the heatmaps.